Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial - Burt, Richard K.; Balabanov, Roumen; Burman, Joachim; Sharrack, Basil; Snowden, John A.; Oliveira, Maria Carolina; Fagius, Jan; Rose, John; Nelson, Flavia; Barreira, Amilton Antunes; Carlson, Kristina; Han, Xiaoqiang; et al. (Jama, 2019)